The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical characteristics and outcome of PIK3CA mutated hormone receptor positive (HR+), human epidermal growth factor 2 negative (HER2-), advanced breast cancer (BC) treated with cyclin-dependent kinase 4/6 inhibitors (CDK4/6i): Real world data.
 
Natalija Dedic Plavetic
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; Lilly O.; Pfizer; Swixx BioPharma
Speakers' Bureau - AstraZeneca; Gilead Sciences; Lilly O.; Novartis; Pfizer; Roche; Swixx BioPharma
Research Funding - Novartis; Roche
 
Katarina Čular
Travel, Accommodations, Expenses - AstraZeneca
 
Marija Križić
Honoraria - Roche; SERVIER
Speakers' Bureau - Gilead Sciences
Travel, Accommodations, Expenses - Gilead Sciences
 
Marina Popovic
Honoraria - AstraZeneca; Gilead Sciences; Novartis; Pfizer (I); Roche
Speakers' Bureau - Gilead Sciences
Research Funding - Novartis; Roche
Travel, Accommodations, Expenses - AstraZeneca; Gilead Sciences
 
Stjepko Plestina
Consulting or Advisory Role - AstraZeneca; BMS GmbH & Co. KG; Lilly O.; MSD; Novartis; Pfizer; PharmaS; Roche; SERVIER
Speakers' Bureau - AstraZeneca; BMS GmbH & Co. KG; Lilly O.; MSD; Novartis; Pfizer; PharmaS; Roche; SERVIER
 
Tajana Silovski
Consulting or Advisory Role - Pfizer; Swixx BioPharma
Speakers' Bureau - AstraZeneca; Lilly O.; Novartis; Pfizer; Roche
Research Funding - Pierre Fabre
Travel, Accommodations, Expenses - AstraZeneca; Roche